Pumares CJ, Estrada SLA, Hernández R?, Jiménez VX

Language: Spanish
References: 8
Page: 22-26
PDF size: 205.53 Kb.

ABSTRACT

Iatrogenic alogenosis or disease by modeling is produced by the indiscriminate use of allogenic or exogenous substances. It is a procedure used since the nineteenth century for aesthetic purposes to improve body contouring. In Mexico, it is a frequent practice; currently represents a serious public health problem. The lack of knowledge of the pathophysiology of iatrogenic alogenosis and the lack of information of patients and medical personnel leads to complications that worsen or exacerbate a picture of silent immunological characteristics. The spectrum of the disease in its local clinical presentation as systemic, is a direct consequence of the activation of the immune system before the infiltration of foreign substances with a high degree of antigenicity and low degree of biocompatibility. The evaluation of the disease can be done qualitatively by clinical evaluation of nonspecific symptoms of a rheumatic disease, by histopathological or imaging evaluation, or even in a quantitative way by direct measurement of acute phase reactants, antibodies or autoantibodies that focus the diagnosis towards a disease of immunological cause and effect. We present a case of disease by modeling associated with breast cancer.

REFERENCES

1. Vera-Lastra O, Medina G, Cruz-Dominguez Mdel P, Ramirez P, Gayosso-Rivera JA, Anduaga-Dominguez H et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld's syndrome). Lupus. 2012; 21 (2): 128-135.

2. Juárez A, Durán MA, Rivera AM, Tellez SE, Buitrón R, Islas LP. Enfermedad humana por adyuvante en el embarazo. Clin Invest Gin Obst. 2013; 40 (6): 277-278.

3. Zimmermann U, Clerici TJ. The Histological aspects of fillers complications. Semin Cutan Med Surg. 2004; 23: 241-250.

4. Curiel JJ. Mastitis por modelantes. Patología Rev Latinoam. 2010; 48 (3): 216-218.

5. Priego BRB, Cárdenas RJ, Pérez CR, Rincón LR, Torres GB, Haddad JL. Enfermedad humana por modelantes. Análisis de sustancias con espectrometría de resonancia magnética. Cir Plast. 2010; 20 (3): 120-123.

6. Torres GB, Burgos VR, Medrano RG, Priego BRB. Instrumento para evaluar y estadificar el daño producido por la infiltración de sustancias modelantes. Cir Plast. 2010; 20 (3): 105-111.

7. Ortiz-Monasterio F, Trigos I. Management of patients with complications from injections of foreign materials into the breasts. Plast Reconstr Surg. 1972; 50 (1): 42-47.

8. Cabral AR, Alcocer-Varela J, Orozco-Topete R, Reyes E, Fernández-Domínguez L, Alarcón-Segovia D. Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Rev Invest Clin. 1994; 46 (4): 257-266.